Clinical Trial Update: Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for PR001 in infants with Gaucher disease type 2 (PROVIDE), currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease Type

Drugs mentioned

• PR001

Snippet

Sponsor: Prevail Therapeutics | Conditions: Gaucher Disease, Type 2 | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING